Cutaneous T-cell Lymphoma Progression: A Potential Dupilumab Pitfall

Dupilumab is a monoclonal antibody inhibiting key drivers in the inflammatory signaling cascade. It has been considered a saving grace for many patients suffering from severe atopic dermatitis and has quickly become a widespread treatment option for many inflammatory pathologies. However, recent rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Malick, Hamza, Wilson, Allessia, Hall, Marshall, Meier, Marshall
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475311/
https://www.ncbi.nlm.nih.gov/pubmed/37667719
http://dx.doi.org/10.7759/cureus.42959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475311/
https://www.ncbi.nlm.nih.gov/pubmed/37667719
http://dx.doi.org/10.7759/cureus.42959

Ejemplares similares